 Good evening. I am Patrick Paveoile. I am a professor and chair of the Department of Microbial Pathogenesis at the University in Maryland in Baltimore, and I'm also FEMS Director for Research and Publication. This presentation is going to be about the portfolio, the FEMS portfolio of journals. I'm emphasizing the present and the future of the FEMS publication for portfolio. Until 2019, FEMS published five journals, Microbiology, Microbiology Letters, Microbiology Reviews, Pathogenesis and Yeast Research. These journals are all published on the hybrid publishing platform, which means that there are two options. It is either free to publish, but the catch is that the publication is only accessible to subscribing institutions. Or you can publish in open access either gold where you pay an APC or green where there is a delay of one year for publication. All contents are made freely available one year after publication. The journals are doing well. The clarivate impact factor, previously called the Reuters impact factor, is either steady for pad and FEMS letters or rising. We've seen some really significant rise of the impact factor for microbiology reviews, yeast research and microbiology in recent years. What has happened in 2020 is that FEMS has launched two new journals, in open access journals. FEMS Microbes and MicroLife, and I'm going to spend some time to tell you more about this in a minute. Both those journals are open access, so they are immediately accessible to all. Of course, there is an APC to publish, but I want to emphasize that all FEMS Society members have the opportunity to have discounts to publish in those journals. The authors will sign a Creative Common Open Access license. We may talk about this later if you like to find out what this is. MicroLife is intended to be the journal for the European Academy of Microbiology. It is intended to be a high-profile journal, so-called the EMBO journal for microbiology. It is broad-scoped, covers all microbes and all aspects of microbiology, and it publishes full-length research articles, short reviews, commentaries, and perspectives, including output from EAM working groups, which are very interesting. And there have been some very interesting workshops and working groups from the EM recently. These are the chief editors, so we have a team of chief editors Axel Brackage from the University of Vienna, a microbiologist slash biotech expert, Carmen Buck-Riezer from the Pasteur Institute in Paris, microbial pathogenesis expert, Matthias Orne from the University of Vienna, an evolutionary microbiologist, and Paula Trackman from the University of South Carolina, who is a card-carrying biologist. Femmes Microbe is a journal for all microbes and all microbiologists alike. It is intended to be a high-volume, high-quality venue for publication of high-quality research. It really emphasizes the support of early-career researchers. It's also broad-scoped and covers all microbes and aspects of microbiology, and it also publishes full-length research articles, short reviews, commentaries, and perspectives. We also have an all-women team of chief editors, Jan Ayas from the University of Aurebro in Sweden, Kathleen Scott from the University of South Florida, and Kimberly Klein from the University of Singapore. I have listed the website you can visit and learn a lot more about this journal, these new journals, and the holder one on the website at OUP or at Femmes.